Tradestie Institutional Equity Comparison Engine

STEX vs NMTC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMTC Overall Edge

NMTC Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NeuroOne Medical Technologies Corporation Common Stock (NMTC) driven by superior Growth & Margin, Momentum & Technical while STEX counters with relative strength in Options & Structure. Fundamentally, STEX trades at N/M Forward P/E with -36966.7% operating margin (+0.0% YoY revenue) versus NMTC at N/M Forward P/E and -63.4% operating margin (+16.3% YoY). In options structure, STEX sits in UNCLASSIFIED (61st %ile IV; Dealer Gamma Walls on Pro) against NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
STEX N/M vs NMTC N/M Fwd P/E
Growth & Margin Winner NMTC
Op Margin -36966.7% vs -63.4% ยท YoY +0.0% vs +16.3%
Momentum & Technical Winner NMTC
1Y -91.3% vs +3.5% ยท 52W Pos 2% vs 2%
Options & Structure Winner STEX
UNCLASSIFIED (61st %ile IV) vs UNCLASSIFIED (N/A IV)
STEX NASDAQ
Streamex Corp. Common Stock
Electromedical & Electrotherapeutic Apparatus
$0.33
+8.54% 1D
Market Cap $56.2M
1M Return -8.56%
1Y Return -91.32%
Forward P/E N/M
Unified AI Score
51.3 / 100 HOLD
Tech 68.0 Fund 63.0 Flow 72.0 Mom 64.0
NMTC NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap $6.1M
1M Return -33.46%
1Y Return +3.49%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 60.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STEX -91.32% NMTC +3.49% Spread: +94.81 pp (NMTC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period STEX Revenue NMTC Revenue STEX Op. Margin NMTC Op. Margin Margin Edge
FY2012 N/A $0M N/A -1491.1% NMTC
FY2013 N/A $0M N/A -2009.0% NMTC
FY2014 N/A $0M N/A -4646.1% NMTC
FY2021 $0M $0M -7576.2% -5735.9% NMTC
FY2022 $0M $0M -9533.2% -5860.2% NMTC
FY2023 $0M $0M -158400.0% -612.3% NMTC
FY2024 $0M $0M -32155.0% -344.3% NMTC
FY2025 N/A $10M N/A -46.5% NMTC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STEX (3) vs NMTC (5)
Institutional Metric STEX NMTC Criterion Row Winner
Market Capitalization Scale $56.2M $6.1M Larger Scale STEX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +16.3% Higher Growth NMTC
Operating Margin (TTM) Profitability -36966.7% -63.4% Higher Margin NMTC
Net Profit Margin Profitability 0.0% -59.7% Higher Margin STEX
Return on Equity (ROE) Capital Efficiency -775.2% -124.7% Higher ROE NMTC
52-Week Range Position Momentum 2% ($0โ€“$5) 2% ($1โ€“$5) Stronger Trend NMTC
Beta / 30D Volatility Risk Regime 1.71ฮฒ ยท 127% Vol 1.55ฮฒ ยท 105% Vol Lower Realized Risk NMTC
Unified Institutional Score Composite Signal 51.3 / 100 (HOLD) 45.5 / 100 (HOLD) Higher Composite STEX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STEX vs NMTC Buy Guide
STEX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 61st %ile
IV Regime Elevated (60thโ€“80th %ile)
Live STEX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NMTC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMTC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STEX nor NMTC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.